Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS

v3.22.2.2
CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2022
Dec. 31, 2021
Jun. 30, 2021
Dec. 31, 2020
Beginning Balance $ (1,327,740) $ (1,356,358) $ (1,308,547) $ (1,291,704)        
Common Stock Value 131   131     $ 117    
Capital in excess of par value 1,242,618 1,163,910 1,091,907 1,158,198        
Distributable Earnings (loss) 84,994 192,332 216,523 133,391        
Net increase in net assets resulting from operations 53,202 23,549 39,548 170,443        
Public offering, net of offering expenses 42,854 (10) 189,958 (208)        
Issuance of common stock due to stock option exercises 266 180 720 3,813        
Retired shares from net issuance and for restricted stock vesting (176) (52) (208) (1,141)        
Distributions reinvested in common stock $ 949 $ 947 $ 2,895 $ 3,057        
Distributions reinvested in common stock (Shares) 62,726 55,413 184,197 189,356        
Distributions $ (63,950) $ (45,190) $ (181,825) $ (133,143)        
Stock-based compensation (1) 2,495 [1] 2,622 [2] 8,333 [1] 7,785 [2]        
Capital in excess of par value 1,288,341 1,166,725 1,288,341 1,166,725        
Distributable Earnings (loss) 74,246 170,691 74,246 170,691        
Ending Balance $ (1,362,718) $ (1,337,532) $ (1,362,718) $ (1,337,532)        
Ending Balance (Shares) 130,191,000 115,925,000 130,191,000 115,925,000        
Restricted Stock                
Retired shares from net issuance and for restricted stock vesting $ (662) $ (872) $ (5,250) $ (4,778)        
Common Stock                
Beginning Balance (Shares) 127,285,000 115,867,000 116,619,000 114,726,000        
Common Stock Value $ 131 $ 116 $ 131 $ 116 $ 128 $ 117 $ 116 $ 115
Public offering, net of offering expenses $ 3   $ 12          
Public offering, net of offering expenses (Shares) 2,866,000   11,787,000          
Issuance of common stock due to stock option exercises (Shares) 22,000 14,000 59,000 277,000        
Retired shares from net issuance and for restricted stock vesting (Shares) (12,000) (3,000) (14,000) (65,000)        
Issuance of common stock under restricted stock plan     $ 1 $ 1        
Issuance of common stock under restricted stock plan (Shares) 23,000 38,000 811,000 998,000        
Distributions reinvested in common stock (Shares) 63,000 55,000 184,000 189,000        
Issuance of common stock from conversion of 2022 Convertible Notes     $ 1          
Issuance of common stock from conversion of 2022 Convertible Notes     981,000          
Distributions $ (63,421) $ (44,770) $ (180,114) $ (131,829)        
Ending Balance (Shares) 130,191,000 115,925,000 130,191,000 115,925,000        
Common Stock | Restricted Stock                
Retired shares from net issuance and for restricted stock vesting (Shares) (56,000) (46,000) (236,000) (200,000)        
Capital in Excess of Par Value                
Public offering, net of offering expenses $ 42,851 $ (10) $ 189,946 $ (208)        
Issuance of common stock due to stock option exercises 266 180 720 3,813        
Retired shares from net issuance and for restricted stock vesting (176) (52) (208) (1,141)        
Issuance of common stock under restricted stock plan     (1) (1)        
Distributions reinvested in common stock 949 947 2,895 3,057        
Issuance of common stock from conversion of 2022 Convertible Notes     (1)          
Stock-based compensation (1) 2,495 [1] 2,622 [2] 8,333 [1] 7,785 [2]        
Capital in Excess of Par Value | Restricted Stock                
Retired shares from net issuance and for restricted stock vesting (662) (872) (5,250) (4,778)        
Distributable Earnings (Loss)                
Net increase in net assets resulting from operations 53,202 23,549 39,548 170,443        
Distributions $ (63,950) $ (45,190) $ (181,825) $ (133,143)        
[1] Stock-based compensation includes $36 thousand and $113 thousand of restricted stock and option expense related to director compensation for the three and nine months ended September 30, 2022, respectively.
[2] Stock-based compensation includes $36 thousand and $86 thousand of restricted stock and option expense related to director compensation for the three and nine months ended September 30, 2021, respectively.